GRF6019

DRUG2 trials

Sponsors

Alkahest, Inc.

Conditions

Alzheimer DiseaseMild to Moderate Alzheimer DiseaseSevere Alzheimer Disease

Phase 2

A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease

CompletedNCT03520998

Alkahest, Inc.Alzheimer Disease, Mild to Moderate Alzheimer Disease

Start: 2018-04-16End: 2019-05-24Updated: 2021-01-29

A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease

CompletedNCT03765762

Alkahest, Inc.Severe Alzheimer Disease

Start: 2019-01-15End: 2019-12-17Updated: 2021-01-27